H
RMD icon

Hexavest’s ResMed RMD Stock Holding History

Hexavest’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-27
Closed -$7K – 291
2021
Q2 		$7K Sell
27
-662
-96% -$139K ﹤0.01% 318
2021
Q1 		$134K Buy
689
+628
+1,030% +$126K 0.01% 269
2020
Q4 		$13K Buy
61
+13
+27% +$2.59K ﹤0.01% 320
2020
Q3 		$8K Sell
48
-36
-43% -$6.65K ﹤0.01% 375
2020
Q2 		$16K Hold
84
– – ﹤0.01% 344
2020
Q1 		$12K Hold
84
– – ﹤0.01% 378
2019
Q4 		$13K Hold
84
– – ﹤0.01% 390
2019
Q3 		$11K Hold
84
– – ﹤0.01% 459
2019
Q2 		$10K Buy
+84
New +$9.3K ﹤0.01% 488

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hexavest's RMD Position: Q3 2021 in Review

Hexavest sold out of ResMed (RMD) in Q3 2021, closing a stake of 27 shares — an estimated $7K sold.

Hexavest first reported a position in RMD in Q2 2019 and held it in 9 quarters. The position peaked at $134K in Q1 2021. 687 funds tracked by Wall St. Rank hold RMD as of Q3 2021.

  • Hexavest reported no remaining ResMed position as of Q3 2021 after selling out during the quarter.
  • Hexavest sold 27 ResMed shares in Q3 2021, an estimated $7K.
  • Hexavest first reported a position in ResMed in Q2 2019 and held it in 9 quarters.
  • Hexavest's ResMed position peaked at $134K in Q1 2021.
  • 687 funds tracked by Wall St. Rank held ResMed as of Q3 2021.

Based on Hexavest's 13F filing for Q3 2021, filed 27 Oct 2021.